UBS Group’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-21,127
| Closed | -$1.36M | – | 8741 |
|
|
2018
Q3 | $1.36M | Buy |
21,127
+12,393
| +142% | +$755K | ﹤0.01% | 3556 |
|
|
2018
Q2 | $426K | Sell |
8,734
-1,048
| -11% | -$54.3K | ﹤0.01% | 4444 |
|
|
2018
Q1 | $460K | Sell |
9,782
-227
| -2% | -$10.9K | ﹤0.01% | 4268 |
|
|
2017
Q4 | $499K | Sell |
10,009
-9,247
| -48% | -$459K | ﹤0.01% | 4295 |
|
|
2017
Q3 | $1.11M | Sell |
19,256
-342
| -2% | -$20.3K | ﹤0.01% | 3622 |
|
|
2017
Q2 | $1.32M | Sell |
19,598
-28,144
| -59% | -$1.78M | ﹤0.01% | 3370 |
|
|
2017
Q1 | $3.13M | Buy |
47,742
+2,281
| +5% | +$141K | ﹤0.01% | 2512 |
|
|
2016
Q4 | $2.58M | Buy |
45,461
+25,240
| +125% | +$1.46M | ﹤0.01% | 2682 |
|
|
2016
Q3 | $1.2M | Buy |
20,221
+6,589
| +48% | +$395K | ﹤0.01% | 3291 |
|
|
2016
Q2 | $891K | Buy |
13,632
+546
| +4% | +$37.1K | ﹤0.01% | 3483 |
|
|
2016
Q1 | $906K | Sell |
13,086
-30,730
| -70% | -$2.05M | ﹤0.01% | 3340 |
|
|
2015
Q4 | $3.22M | Sell |
43,816
-1,479
| -3% | -$105K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $3.21M | Sell |
45,295
-2,872
| -6% | -$233K | ﹤0.01% | 2307 |
|
|
2015
Q2 | $4.19M | Buy |
48,167
+6,412
| +15% | +$484K | ﹤0.01% | 2255 |
|
|
2015
Q1 | $3.07M | Buy |
41,755
+29,363
| +237% | +$2.08M | ﹤0.01% | 2530 |
|
|
2014
Q4 | $891K | Buy |
+12,392
| New | +$859K | ﹤0.01% | 3669 |
|
Other funds holding LPNT
UBS Group's LPNT Position: Q4 2018 in Review
UBS Group sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 21,127 shares — an estimated $1.36M sold.
UBS Group first reported a position in LPNT in Q4 2014 and held it in 16 quarters. The position peaked at $4.19M in Q2 2015. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- UBS Group reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- UBS Group sold 21,127 LifePoint Health, Inc. shares in Q4 2018, an estimated $1.36M.
- UBS Group first reported a position in LifePoint Health, Inc. in Q4 2014 and held it in 16 quarters.
- UBS Group's LifePoint Health, Inc. position peaked at $4.19M in Q2 2015.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.